Influx Healthtech IPO listing price is ₹ 132.50, issue price is ₹ 96.00, and currently trading at ₹ 157.45 as on July 17, 2025. Influx Healthtech IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Influx Healthtech IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Healthcare sector. Rarever Financial Advisors is the merchant banker of Influx Healthtech IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 4th February 2025.
Influx Healthtech IPO offer price is ₹ 96.00 and got listed at ₹ 132.50. Read Influx Healthtech IPO details mentioned above.The IPO of Influx Healthtech Limited was listed on 25th June 2025. As of today, Influx Healthtech IPO is trading at ₹ 157.45, compared to the previous day’s close of ₹ 161.40. Read the report above for detailed IPO performance.
The issue price of Influx Healthtech IPO was ₹ 96.00 per equity share.
Influx Healthtech IPO was listed at ₹132.50 on the stock exchange on 25th June 2025. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of July 17, 2025, the current market price of Influx Healthtech IPO is ₹ 157.45.
The 52-week high for Influx Healthtech IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Influx Healthtech IPO listed at ₹ 132.50 against the issue price of ₹ 96.00 per equity share, showing a listing day gain/loss of 36.5 (38.02%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Influx Healthtech IPO stock moved from its listing price of ₹ 132.50 to the current price of ₹157.45 per equity share, reflecting a change of 18.83% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Influx Healthtech IPO issue date of 25th June 2025 and CMP of ₹157.45, the estimated CAGR is approximately 256889.99%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Influx Healthtech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Influx Healthtech Financial Review Page
Merchant Banker(s) of Influx Healthtech IPO: Rarever Financial Advisors Private Limited
Influx Healthtech IPO subscription was 201.35 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Influx Healthtech IPO listed at a listing price of 132.50 against the offer price of 96.00.
The current market price of Influx Healthtech is 157.45.
Why Us?